Cetirizine Hydrochloride Oral Solution
Product Images NDC 83745-185

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cetirizine Hydrochloride Oral Solution (NDC 83745-185). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apozeal Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottlelabel120ml (Bottlelabel 120ml)

This text provides information about an oral solution containing cetirizine hydrochloride, with each milliliter containing 1 mg of the active ingredient. The dosage and additional instructions should be reviewed in the prescribing information accompanying the product. The solution should be stored in a tight, light-resistant container at the recommended temperature range. The manufacturing details indicate that the product is made in the USA by Apozeal Pharmaceuticals Inc. It is intended for oral use only and should be dispensed with a prescription.*

FDA Label Image

Bottlelabel240ml (Bottlelabel240ml)

This text provides information about a medication called Cetirizine Hydrochloride Oral Solution, USP, with each milliliter containing 1 mg of the active ingredient. The dosage instructions and storage conditions are included, along with details about the manufacturer, Apozeal Pharmaceuticals Inc., located in Levittown, PA. The product is made in the USA and is for oral use only. This oral solution is available in a 240 mL container and is prescription-only.*

FDA Label Image

Bottlelabel480ml (Bottlelabel480ml)

This text is a description of a medication containing 1 mg of cetirizine hydrochloride per milliliter. The dosage and usage instructions are not provided, and it is recommended to refer to the accompanying prescribing information. The medication is to be dispensed in tight, light-resistant containers and stored at temperatures between 20°C-25°C (68°F-77°F). Excursions are allowed within 15°C-30°C (59°F-86°F). The product is manufactured by Apozeal Pharmaceuticals Inc. in the USA and has an expiration date of September 2024. The NDC number is 83745-185-16, and it is an oral solution for use.*

FDA Label Image

Chemstructure (Chemstruc)

FDA Label Image

Logo (Logo)

This text is not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.